Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial

Published:2021-12-14 Issue: Volume: Page:1-7
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Liu Xiaoyu¹,Yang Wanqi²,Zhang Chao¹,Wu Heng³,Wang Ruize¹,Ding Qiang³,Hu Yan³,Xiong Yongli²,Zhang Shaobai¹,Wang Lin²^ORCID

Affiliation:

1. Center for Clinical Evaluation of Vaccines, Shaanxi Provincial Center for Disease Control and Prevention, Xi’an, China

2. Sinovac Biotech Co. Ltd, Beijing, China

3. Department of Immunology, Hanbin District Center for Disease Control and Prevention, Ankang, China

Funder

Sinovac Biotech Co. Ltd

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.2010428

Reference25 articles.

1. Clinical features, diagnosis, and management of enterovirus 71

2. The Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine Development

3. An Apparently New Enterovirus Isolated from Patients with Disease of the Central Nervous System

4. Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and 6-month immune persistence of inactivated poliovirus vaccine (Sabin strains) simultaneously administrated with other vaccines for primary and booster immunization in Jiangxi Province, China;Vaccine;2024-08

2. Research progress on pathogenic and therapeutic mechanisms of Enterovirus A71;Archives of Virology;2023-09-29

3. Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6–7 Months: A Phase 4, Randomized, Controlled Trial;Vaccines;2023-04-18

4. Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China;Frontiers in Immunology;2022-12-08

5. Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial;Vaccine;2022-08